Literature DB >> 20804775

Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Doodipala Samba Reddy1, Omkaram Gangisetty, Seema Briyal.   

Abstract

Progesterone (P) is an endogenous anticonvulsant hormone. P is being evaluated as a treatment for epilepsy, traumatic brain injury, and other complex neurological conditions. Preclinical and clinical studies suggest that P appears to interrupt epileptogenic events. However, the potential disease-modifying effect of P in epileptogenic models is not widely investigated. In this study, we examined the effects of P on the development of hippocampus kindling in female mice. In addition, we determined the role of progesterone receptors (PR) in the P's effect on the kindling epileptogenesis utilizing PR knockout (PRKO) mice. P, at 25 mg/kg, did not affect seizures and did not exert sedative/motor effects in fully-kindled mice. P treatment (25 mg/kg, twice daily for 2 weeks) significantly suppressed the rate of development of behavioral kindled seizure activity evoked by daily hippocampus stimulation in wild-type (WT) mice, indicating a disease-modifying effect of P on limbic epileptogenesis. There was a significant increase in the rate of 'rebound or withdrawal' kindling during drug-free stimulation sessions following abrupt discontinuation of P treatment. A washout period after termination of P treatment prevented such acceleration in kindling. PRKO mice were kindled significantly slower than WT mice, indicating a modulatory role of PRs in seizure susceptibility. P's effects on early kindling progression was partially decreased in PRKO mice, but the overall (˜2-fold) delay in the rate of kindling for the induction of stage 5 seizures was unchanged in PRKO mice. Moreover, the acute anticonvulsant effect of P was undiminished in fully-kindled PRKO mice. These studies suggest that P exerts disease-modifying effects in the hippocampus kindling model at doses that do not significantly affect seizure expression and motor performance, and the kindling-retarding effects of P may occur partly through a complex PR-dependent and PR-independent mechanism.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804775      PMCID: PMC2963708          DOI: 10.1016/j.neuropharm.2010.08.017

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  70 in total

1.  A new device for the rapid measurement of impaired motor function in mice.

Authors:  L L Coughenour; J R Mclean; R B Parker
Journal:  Pharmacol Biochem Behav       Date:  1977-03       Impact factor: 3.533

2.  Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.

Authors:  Giuseppe Biagini; Enrica Baldelli; Daniela Longo; Luca Pradelli; Isabella Zini; Michael A Rogawski; Massimo Avoli
Journal:  Exp Neurol       Date:  2006-06-14       Impact factor: 5.330

3.  Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

Authors:  W Löscher; D Hönack; C Rundfeldt
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

Review 4.  Progesterone for the treatment of experimental brain injury; a systematic review.

Authors:  Claire L Gibson; Laura J Gray; Philip M W Bath; Sean P Murphy
Journal:  Brain       Date:  2007-08-21       Impact factor: 13.501

Review 5.  From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options.

Authors:  Asla Pitkänen; Riikka J Immonen; Olli H J Gröhn; Irina Kharatishvili
Journal:  Epilepsia       Date:  2009-02       Impact factor: 5.864

Review 6.  A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons.

Authors:  K W Gee; L D McCauley; N C Lan
Journal:  Crit Rev Neurobiol       Date:  1995

7.  Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats.

Authors:  S Mohammad; A Abolhassan; M H Pourgholami
Journal:  Epilepsy Res       Date:  1998-05       Impact factor: 3.045

8.  A pharmacological study in the kindling model of epilepsy.

Authors:  T E Albertson; R M Joy; L G Stark
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

9.  Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.

Authors:  Claudia Brandt; Maike Glien; Alexandra M Gastens; Maren Fedrowitz; Kerstin Bethmann; Holger A Volk; Heidrun Potschka; Wolfgang Löscher
Journal:  Neuropharmacology       Date:  2007-05-18       Impact factor: 5.250

10.  Progesterone synthesis and myelin formation by Schwann cells.

Authors:  H L Koenig; M Schumacher; B Ferzaz; A N Thi; A Ressouches; R Guennoun; I Jung-Testas; P Robel; Y Akwa; E E Baulieu
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

View more
  26 in total

Review 1.  Clinical Potential of Neurosteroids for CNS Disorders.

Authors:  Doodipala Samba Reddy; William A Estes
Journal:  Trends Pharmacol Sci       Date:  2016-05-05       Impact factor: 14.819

Review 2.  Sex differences in the anticonvulsant activity of neurosteroids.

Authors:  Doodipala Samba Reddy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

3.  PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields.

Authors:  Doodipala Samba Reddy; Omkaram Gangisetty; Xin Wu
Journal:  Brain Res       Date:  2017-01-28       Impact factor: 3.252

4.  Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity.

Authors:  Chase Matthew Carver; Xin Wu; Omkaram Gangisetty; Doodipala Samba Reddy
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

Review 5.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

6.  Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABA(A) Receptors.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

Review 7.  Neurosteroids and their role in sex-specific epilepsies.

Authors:  Doodipala Samba Reddy
Journal:  Neurobiol Dis       Date:  2014-06-21       Impact factor: 5.996

8.  Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis.

Authors:  Doodipala Samba Reddy; G Ramanathan
Journal:  Epilepsy Behav       Date:  2012-07-24       Impact factor: 2.937

Review 9.  Neurosteroid regulation of GABAA receptors: A role in catamenial epilepsy.

Authors:  Suchitra Joshi; Jaideep Kapur
Journal:  Brain Res       Date:  2018-02-23       Impact factor: 3.252

10.  3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-03-30       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.